1-20 of 22
Christopher R. Flowers
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

American Society of Hematology: building a comprehensive minority recruitment and retention professional program

Margo R. Rollins, Rahma M. Warsame, Melody Smith, Arturo Molina, Rayne H. Rouce, Belinda R. Avalos, Cage S. Johnson, Jose A. Lopez, Alexis A. Thompson, Lisa Fanning, Patricia Frustace, Keelin Roche, Nathalie van Havre, Devon Mack, Christopher R. Flowers, Deirdra R. Terrell
Journal: Blood Advances
Blood Adv (2024) 8 (24): 6237–6247.
https://doi.org/10.1182/bloodadvances.2024013519
Published: 2024
Journal Articles

Treatment Patterns and Outcomes in Follicular Lymphoma with POD24: An Analysis from The LEO Consortium

Jonathan R Day, Melissa C. Larson, Urshila Durani, Jean L Koff, Yucai Wang, Thomas M. Habermann, Izidore S Lossos, Loretta J. Nastoupil, Christopher S Strouse, Dai Chihara, Peter Martin, John P. Leonard, Jonathon B Cohen, Brad S. Kahl, Jia Ruan, Richard Burack, Jonathan W. Friedberg, James R Cerhan, Christopher R. Flowers, Brian L Link, Matthew J. Maurer, Carla Casulo
Journal: Blood Advances
Blood Adv bloodadvances.2024014053.
https://doi.org/10.1182/bloodadvances.2024014053
Published: 2024
Includes: Supplemental data
Journal Articles

Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCL

Arushi Khurana, Raphael Mwangi, Loretta J. Nastoupil, Patrick M. Reagan, Umar Farooq, Jason T. Romancik, Timothy J. McDonnell, Shaun M. Riska, lzidore S. Lossos, Brad S. Kahl, Peter Martin, Thomas E. Witzig, James R. Cerhan, Christopher R. Flowers, Grzegorz S. Nowakowski, Matthew J. Maurer
Journal: Blood Advances
Blood Adv (2024) 8 (16): 4414–4422.
https://doi.org/10.1182/bloodadvances.2024012838
Published: 2024
Includes: Supplemental data
Journal Articles

Impact of patient demographics and neighborhood socioeconomic variables on clinical trial participation patterns for NHL

Clinical Trials & Observations
Chijioke Nze, Clark R. Andersen, Amy A. Ayers, Jason Westin, Michael Wang, Swaminathan Iyer, Sairah Ahmed, Chelsea Pinnix, Francisco Vega, Lynne Nguyen, Lorna McNeill, Loretta J. Nastoupil, Kehe Zhang, Cici X. Bauer, Christopher R. Flowers
Journal: Blood Advances
Blood Adv (2024) 8 (14): 3825–3837.
https://doi.org/10.1182/bloodadvances.2023011040
Published: 2024
Includes: Supplemental data
Journal Articles

Defining primary refractory large B-cell lymphoma

Allison M. Bock, Raphael Mwangi, Yucai Wang, Arushi Khurana, Matthew J. Maurer, Amy Ayers, Brad S. Kahl, Peter Martin, Jonathon B. Cohen, Carla Casulo, Izidore S. Lossos, Umar Farooq, Sabarish Ayyappan, Tanner Reicks, Thomas M. Habermann, Thomas E. Witzig, Christopher R. Flowers, James R. Cerhan, Loretta J. Nastoupil, Grzegorz S. Nowakowski
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3402–3415.
https://doi.org/10.1182/bloodadvances.2024012760
Published: 2024
Includes: Supplemental data
Journal Articles

Cardiovascular events reported in patients with B-cell malignancies treated with zanubrutinib

Clinical Trials & Observations
Javid J. Moslehi, Richard R. Furman, Constantine S. Tam, Joe-Elie Salem, Christopher R. Flowers, Aileen Cohen, Meng Zhang, Jun Zhang, Lipeng Chen, Han Ma, Jennifer R. Brown
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2478–2490.
https://doi.org/10.1182/bloodadvances.2023011641
Published: 2024
Includes: Supplemental data
Journal Articles

Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS

Clinical Trials & Observations
Douglas E Gladstone, Franco D'Alessio, Christopher Howard, Mi-Ae Lyu, Jason R. Mock, Kevin W. Gibbs, Darryl Abrams, Meixian Huang, Ke Zeng, James P. Herlihy, Sergio T. Castillo, Roland Bassett, Tara Sadeghi, Simrit Parmar, Christopher R. Flowers, Siddhartha Mukherjee, David Schoenfeld, Peter F. Thall, Arthur S. Slutsky
Journal: Blood Advances
Blood Adv (2023) 7 (13): 3075–3079.
https://doi.org/10.1182/bloodadvances.2022009619
Published: 2023
Journal Articles

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Clinical Trials & Observations
Narendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Max J. Gordon, Alexey V. Danilov, Natalie S. Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T. Hill, Nilanjan Ghosh, Steven I. Park, David A. Bond, Mehdi Hamadani, Timothy S. Fenske, Peter Martin, Mary-Kate Malecek, Brad S. Kahl, Christopher R. Flowers, Brian K. Link, Lawrence D. Kaplan, David J. Inwards, Andrew L. Feldman, Eric D. Hsi, Kami Maddocks, Kristie A. Blum, Nancy L. Bartlett, James R. Cerhan, John P. Leonard, Thomas M. Habermann, Matthew J. Maurer, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2287–2296.
https://doi.org/10.1182/bloodadvances.2022009225
Published: 2023
Includes: Supplemental data
Journal Articles

A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL

Clinical Trials & Observations
Hua-Jay J. Cherng, Stefan K. Alig, Yasuhiro Oki, Loretta J. Nastoupil, Luis Fayad, Sattva S. Neelapu, Francesco Turturro, Fredrick Hagemeister, Alexander F. M. Craig, Charles W. Macaulay, Maria Alma Rodriguez, Hun Ju Lee, Timothy J. McDonnell, Christopher R. Flowers, Francisco Vega, Michael R. Green, Lei Feng, David M. Kurtz, Ash A. Alizadeh, R. Eric Davis, Jason R. Westin
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1137–1145.
https://doi.org/10.1182/bloodadvances.2022008174
Published: 2023
Journal Articles

Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysis

Danny Luan, Tolulope Fatola, Ahmed Toure, Christopher R. Flowers, Brian Link, Jonathan W. Friedberg, Jonathon B. Cohen, Brad Kahl, Izidore S. Lossos, Loretta Nastoupil, Matthew J. Maurer, James R. Cerhan, Peter Martin
Journal: Blood Advances
Blood Adv (2022) 6 (15): 4413–4423.
https://doi.org/10.1182/bloodadvances.2022007687
Published: 2022
Includes: Supplemental data
Journal Articles

SIRPα + macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab

Mario L. Marques-Piubelli, Edwin R. Parra, Lei Feng, Luisa Solis Soto, Mariana Gallardo, Sushanth Gouni, Felipe Samaniego, Mansoor Noorani, Fredrick B. Hagemeister, Jason R. Westin, Hun Ju Lee, Maria A. Rodriguez, Sattva S. Neelapu, Jillian R. Gunther, Nathan H. Fowler, Christopher R. Flowers, Ignacio I. Wistuba, Loretta J. Nastoupil, Francisco Vega, Paolo Strati
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3286–3293.
https://doi.org/10.1182/bloodadvances.2022007104
Published: 2022
Includes: Supplemental data
Journal Articles

Day 30 SUV max predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy

Ajlan Al Zaki, Lei Feng, Grace Watson, Sairah A. Ahmed, Haleigh Mistry, Loretta J. Nastoupil, Misha Hawkins, Ranjit Nair, Swaminathan P. Iyer, Hun J. Lee, Raphael E. Steiner, Christopher R. Flowers, Elizabeth J. Shpall, Partow Kebriaei, Sattva S. Neelapu, Jason R. Westin, Paolo Strati
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2867–2871.
https://doi.org/10.1182/bloodadvances.2021006715
Published: 2022
Includes: Supplemental data
Journal Articles

Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey

Clinical Trials & Observations
R. Andrew Harkins, Sharvil P. Patel, Michelle J. Lee, Jeffrey M. Switchenko, Stephen M. Ansell, Nancy L. Bartlett, Kristie A. Blum, Amanda F. Cashen, Carla Casulo, Jonathan W. Friedberg, Patrick B. Johnston, Brad S. Kahl, John P. Leonard, Brian K. Link, Izidore S. Lossos, Peter Martin, Matt J. Maurer, Neha Mehta-Shah, Patrick M. Reagan, Jason R. Westin, Jean L. Koff, Christopher R. Flowers
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2745–2756.
https://doi.org/10.1182/bloodadvances.2021006504
Published: 2022
Includes: Supplemental data
Journal Articles

Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement

Serkan Akin, Chitra Hosing, Issa Khouri, Sairah Ahmed, Amin Alousi, Nathan Fowler, Jacinth Joseph, Jonathan Truxillo, Jeremy L. Ramdial, Farzaneh Maadani, Gabriela Rondon, May Daher, Jin S. Im, Raphael Steiner, Jason Westin, Swaminathan P. Iyer, Bouthaina Dabaja, Paolo Anderlini, Uday R. Popat, Muzaffar H. Qazilbash, Christopher R. Flowers, Elizabeth Shpall, Richard E. Champlin, Yago Nieto, Samer A. Srour
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2267–2274.
https://doi.org/10.1182/bloodadvances.2021005602
Published: 2022
Includes: Supplemental data
Journal Articles

Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort data

Clinical Trials & Observations
Laurie H. Sehn, Mark Hertzberg, Stephen Opat, Alex F. Herrera, Sarit Assouline, Christopher R. Flowers, Tae Min Kim, Andrew McMillan, Muhit Ozcan, Violaine Safar, Gilles Salles, Grace Ku, Jamie Hirata, Yi Meng Chang, Lisa Musick, Matthew J. Matasar
Journal: Blood Advances
Blood Adv (2022) 6 (2): 533–543.
https://doi.org/10.1182/bloodadvances.2021005794
Published: 2022
Includes: Supplemental data
Journal Articles

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy

Clinical Trials & Observations
David A. Bond, Jeffrey M. Switchenko, Diego Villa, Kami Maddocks, Michael Churnetski, Alina S. Gerrie, Subir Goyal, Krithika Shanmugasundaram, Oscar Calzada, Bhaskar Kolla, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Brian T. Hill, Yazeed Sawalha, Peter Martin, Edward Maldonado, Max Gordon, Alexey V. Danilov, Natalie S. Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Nilanjan Ghosh, Steven I. Park, Narendranath Epperla, Talha Badar, Jin Guo, Mehdi Hamadani, Timothy S. Fenske, Mary-Kate Malecek, Brad S. Kahl, Christopher R. Flowers, Kristie A. Blum, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5179–5189.
https://doi.org/10.1182/bloodadvances.2021004765
Published: 2021
Includes: Supplemental data
Journal Articles

CRP and ferritin in addition to the EASIX score predict CAR-T–related toxicity

Clinical Trials & Observations
Uri Greenbaum, Paolo Strati, Rima M. Saliba, Janet Torres, Gabriela Rondon, Yago Nieto, Chitra Hosing, Samer A. Srour, Jason Westin, Luis E. Fayad, Hun J. Lee, Swaminathan P. Iyer, Ranjit Nair, Loretta J. Nastoupil, Simrit Parmar, Maria A. Rodriguez, Felipe Samaniego, Raphael E. Steiner, Michael Wang, Chelsea C. Pinnix, Christopher R. Flowers, Sudhakar Tummala, Jeremy L. Ramdial, Fevzi F. Yalniz, Misha Hawkins, Katayoun Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Sattva S. Neelapu, Partow Kebriaei, Sairah Ahmed
Journal: Blood Advances
Blood Adv (2021) 5 (14): 2799–2806.
https://doi.org/10.1182/bloodadvances.2021004575
Published: 2021
Includes: Supplemental data
Journal Articles

Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials

Clinical Trials & Observations
Carla Casulo, Jesse G. Dixon, Fang-Shu Ou, Eva Hoster, Bruce A. Peterson, Howard S. Hochster, Pauline Brice, Marco Ladetto, Wolfgang Hiddemann, Robert Marcus, Eva Kimby, Michael Herold, Tina Nielsen, Franck Morschhauser, Mathias Rummel, Anton Hagenbeek, Umberto Vitolo, Gilles A. Salles, Qian Shi, Christopher R. Flowers
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1737–1745.
https://doi.org/10.1182/bloodadvances.2020002724
Published: 2021
Journal Articles

Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis

Clinical Trials & Observations
Ariela Noy, Sven de Vos, Morton Coleman, Peter Martin, Christopher R. Flowers, Catherine Thieblemont, Franck Morschhauser, Graham P. Collins, Shuo Ma, Shachar Peles, Stephen D. Smith, Jacqueline C. Barrientos, Elizabeth Chong, Shiquan Wu, Leo W.-K. Cheung, Kevin Kwei, Bernhard Hauns, Israel Arango-Hisijara, Robert Chen
Journal: Blood Advances
Blood Adv (2020) 4 (22): 5773–5784.
https://doi.org/10.1182/bloodadvances.2020003121
Published: 2020
Includes: Supplemental data
Journal Articles

The Connect CLL Registry: final analysis of 1494 patients with chronic lymphocytic leukemia across 199 US sites

Clinical Trials & Observations
Anthony Mato, Chadi Nabhan, Nicole Lamanna, Neil E. Kay, David L. Grinblatt, Christopher R. Flowers, Charles M. Farber, Matthew S. Davids, Arlene S. Swern, Kristen Sullivan, E. Dawn Flick, Sarah M. Gressett Ussery, Mecide Gharibo, Pavel Kiselev, Jeff P. Sharman
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1407–1418.
https://doi.org/10.1182/bloodadvances.2019001145
Published: 2020
Includes: Supplemental data